Lack Of Device Identifiers On Recalled Cardiac Devices Cost Medicare $1.5Bn, OIG Says
Medicare lost $1.5bn in claims over a 10-year period to cover procedures to fix or replace seven faulty cardiac devices due to the lack of product-specific information on its claims form for malfunctioning defibrillators and pacemakers, says the US HHS Office of Inspector General. Recalls of Medtronic, Boston Scientific and Abbott/St. Jude Medical cardiac rhythm management devices are likely behind most of the cost.
You may also be interested in...
Alex Azar was confirmed as the next secretary of Health and Human Services with strong industry support. Azar comes to the role with some homework to do on key FDA medtech policies, but has expressed support for risk-based regulation of lab-developed tests and cost-saving bundled-payment models.
Democratic Sens. Patty Murray and Elizabeth Warren pressed US CMS and HHS officials at a recent hearing on making certain a line is added to Medicare claims forms for unique device identifiers, both to reduce Medicare costs and improve patient safety.
The X12 committee, a panel that helps sets standards for insurance documentation in the US, has agreed that Unique Device Identifiers should be added to Medicare and private-payer claims forms, a move that some groups say could make it easier to track long-term safety and performance of implants. But device companies oppose the move.